Evidence map›Paper›PMID 36237246›Full record

ArticleTranslational cancer research2022

Misdiagnosis of primary mucosa-associated lymphoid tissue lymphoma of the pleura: case report and literature review.

Yao-Hui Wang, Ling Peng, Jie-Han Jiang, Yun Xiao, Zhi-Ruo Zhu, De Tong, Zhi-Hui Shi, Wen-Long He, Qing-Wu Qin, Ding Liang and 4 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Yao-Hui Wang *Department of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Ling Peng *Department of Respiratory Disease, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Jie-Han JiangDepartment of Pulmonary and Critical Care Medicine, University of South China Affiliated Changsha Central Hospital of Changsha City, Changsha, China.
Yun XiaoDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Zhi-Ruo ZhuDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
De TongDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Zhi-Hui ShiDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Wen-Long HeDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Qing-Wu QinDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Ding LiangXiangtan Central Hospital, Xiangtan, China.
Yi JiangDepartment of Pathology, Second Xiangya Hospital of Central South University, Changsha, China.
Hong LuoDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Rui ZhouDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Kui XiaoDepartment of Pulmonary and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNSecond Xiangya Hospital of Central South University · CNChangsha Central Hospital · CNHangzhou Medical College · CNXiangyang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mucosa-associated lymphoid tissue (MALT) lymphoma is an indolent B cell lymphoma. Its occurrence in the pleura is rare, with atypical clinical manifestations. MALT of the pleura is easily misdiagnosed. This is the first case report of pleural MALT lymphoma in China. Case Description: We report the case of a 54-year-old Chinese man with no notable medical history who complained of cough, sputum, and shortness of breath for 3 months. He had a positive purified protein derivative (PPD) test. An initial misdiagnosis of pleural tuberculosis was corrected, after 3 thoracoscopic biopsies and tests, to primary pleural MALT lymphoma. He received treatments of R-CHOP (rituximab, cyclophosphamide, epirubicin, vindesine and prednisolone) and traditional Chinese medicine. The patient was followed for 3 years until June 2022, with no obvious respiratory symptoms. Pleural MALT lymphoma is extremely rare, with only a few cases reported. This article describes our case, and includes an overview of 15 previously reported cases to summarize the characteristics, treatments, and prognosis of primary pleural MALT lymphoma. Conclusions: Pleural MALT lymphoma is rare, and a correct diagnosis depends on tissue biopsy, immunohistochemical staining, and detection of gene rearrangement. Thoracoscopy is important to diagnose this disease. Multiple thoracoscopic biopsies may be necessary.

Indexed as

case reportlow-grade B-cell lymphomamedical thoracoscopic biopsyMucosa-associated lymphoid tissue (MALT)pleural dissemination

Identifiers

PMID36237246
PMCPMC9552252
OpenAlexW4294199395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.